TD Cowen Maintains Outperform on Beauty Health, Lowers Price Target to $9
Portfolio Pulse from jenniferd'souza@benzinga.com
TD Cowen analyst Oliver Chen maintains an Outperform rating on Beauty Health (NASDAQ:SKIN) but lowers the price target from $15 to $9.
August 10, 2023 | 3:35 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TD Cowen analyst Oliver Chen maintains an Outperform rating on Beauty Health but lowers the price target from $15 to $9.
The lowering of the price target by TD Cowen from $15 to $9 indicates a potential decrease in the stock's value. However, the maintained Outperform rating suggests that the stock is still expected to outperform the market, which could mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100